EyeGate reported data in its Ocular Bandage Gel (OBG) studies in punctate epitheliopathies (PE) and in corneal wound healing following bilateral photorefractive keratectomy (PRK) surgery. The PRK study showed improved wound healing and the PE trial showed improvement in patient symptoms. EyeGate will meet with the FDA to discuss whether the existing data are sufficient for a 510(k) de novo regulatory filing.
19 Nov 2018
EyeGate Pharmaceuticals - Positive signals in OBG PRK and PE studies
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
EyeGate Pharmaceuticals - Positive signals in OBG PRK and PE studies
Kiora Pharmaceuticals, Inc. (KPRX:NAS) | 0 0 0.0%
- Published:
19 Nov 2018 -
Author:
Pooya Hemami -
Pages:
2
EyeGate reported data in its Ocular Bandage Gel (OBG) studies in punctate epitheliopathies (PE) and in corneal wound healing following bilateral photorefractive keratectomy (PRK) surgery. The PRK study showed improved wound healing and the PE trial showed improvement in patient symptoms. EyeGate will meet with the FDA to discuss whether the existing data are sufficient for a 510(k) de novo regulatory filing.